Clinical trial · no report yet · Phase 3
AML-17
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
- NCT00052299 ↗
- Completed
- European Organisation for Research and Treatment of Cancer - EORTC
- 20 commentary sources found
- Standard
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| Podcasts | 11 | |
| X threads | 5 | |
| YouTube | 4 |
The trial
ClinicalTrials.gov- Official title
- Gemtuzumab Ozogamicin (GO) Combined With Standard Intensive Chemotherapy Versus Standard Intensive Chemotherapy Alone For Induction/Consolidation In Patients 61-75 Years Old With Previously Untreated AML: A Randomized Phase III Trial (AML-17) Of The EORTC-LG and the GIMEMA-ALWP
- Phase
- Phase 3
- Status
- Completed
- Conditions
- Leukemia
- Interventions
- cytarabine; etoposide; gemtuzumab ozogamicin; idarubicin; mitoxantrone hydrochloride
- Arms
- ARM A · Experimental
- ARM B · Active comparator
- Enrollment
- 472
- Primary outcomes
- Overall survival
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC with Gruppo Italiano Malattie EMatologiche dell'Adulto
- Start
- Sep 2002
- Primary completion
- Jan 2008
- Results posted
- No
- Registry record
- NCT00052299 · updated Aug 27, 2012
Publications
linked from the registry- Amadori S, Suciu S, Stasi R, Salih HR, Selleslag D, Muus P, De Fabritiis P, Venditti A, Ho AD, Lubbert M, Thomas X, Latagliata R, Halkes CJ, Falzetti F, Magro D, Guimaraes JE, Berneman Z, Specchia G, Karrasch M, Fazi P, Vignetti M, Willemze R, de Witte T, Marie JP. Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17). J Clin Oncol. 2013 Dec 10;31(35):4424-30. doi: 10.1200/JCO.2013.49.0771. Epub 2013 Oct 14. PubMed 24127442